{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T16:42:17Z","timestamp":1774888937730,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,11]]},"DOI":"10.7759\/cureus.69189","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T15:22:19Z","timestamp":1726068139000},"source":"Crossref","is-referenced-by-count":1,"title":["Pneumocystis jirovecii Pneumonia and HIV-Associated Nephropathy in Acute HIV Infection"],"prefix":"10.7759","author":[{"given":"Sina","family":"Hedayatpour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alla","family":"Albonijim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Avila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32833a3967","article-title":"AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study","volume":"24","author":"Buchacz K","year":"2010","unstructured":"Buchacz K, Baker RK, Palella FJ Jr, et al.. AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study. AIDS. 2010, 24:1549-59. 10.1097\/QAD.0b013e32833a3967","journal-title":"AIDS"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1513\/pats.201009-062WR","article-title":"HIV-associated Pneumocystis pneumonia","volume":"8","author":"Huang L","year":"2011","unstructured":"Huang L, Cattamanchi A, Davis JL, et al.. HIV-associated Pneumocystis pneumonia. Proc Am Thorac Soc. 2011, 8:294-300. 10.1513\/pats.201009-062WR","journal-title":"Proc Am Thorac Soc"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2008.08.005","article-title":"HIV-associated nephropathy: clinical presentation, pathology, and epidemiology in the era of antiretroviral therapy","volume":"28","author":"Wyatt CM","year":"2008","unstructured":"Wyatt CM, Klotman PE, D'Agati VD. HIV-associated nephropathy: clinical presentation, pathology, and epidemiology in the era of antiretroviral therapy. Semin Nephrol. 2008, 28:513-22. 10.1016\/j.semnephrol.2008.08.005","journal-title":"Semin Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2006.04.013","article-title":"HIV-associated nephropathy","volume":"13","author":"Khan S","year":"2006","unstructured":"Khan S, Haragsim L, Laszik ZG. HIV-associated nephropathy. Adv Chronic Kidney Dis. 2006, 13:307-13. 10.1053\/j.ackd.2006.04.013","journal-title":"Adv Chronic Kidney Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1089\/108729101750301915","article-title":"Treatment of HIV-associated nephropathy","volume":"15","author":"Sothinathan R","year":"2001","unstructured":"Sothinathan R, Briggs WA, Eustace JA. Treatment of HIV-associated nephropathy. AIDS Patient Care STDS. 2001, 15:363-71. 10.1089\/108729101750301915","journal-title":"AIDS Patient Care STDS"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00152.x","article-title":"HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy","volume":"58","author":"Barisoni L","year":"2000","unstructured":"Barisoni L, Bruggeman LA, Mundel P, D'Agati VD, Klotman PE. HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy. Kidney Int. 2000, 58:173-81. 10.1046\/j.1523-1755.2000.00152.x","journal-title":"Kidney Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00283.x","article-title":"Critical role for Nef in HIV-1-induced podocyte dedifferentiation","volume":"64","author":"Sunamoto M","year":"2003","unstructured":"Sunamoto M, Husain M, He JC, Schwartz EJ, Klotman PE. Critical role for Nef in HIV-1-induced podocyte dedifferentiation. Kidney Int. 2003, 64:1695-701. 10.1046\/j.1523-1755.2003.00283.x","journal-title":"Kidney Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)10363-X","article-title":"Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria","volume":"354","author":"Ruggenenti P","year":"1999","unstructured":"Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M, Scolari F, Schena FP, Remuzzi G. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet. 1999, 354:359-64. 10.1016\/S0140-6736(98)10363-X","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-12-14","article-title":"HIV patients treated with low-dose prednisolone exhibit lower immune activation than untreated patients","volume":"12","author":"Kasang C","year":"2012","unstructured":"Kasang C, Ulmer A, Donhauser N, et al.. HIV patients treated with low-dose prednisolone exhibit lower immune activation than untreated patients. BMC Infect Dis. 2012, 12:14. 10.1186\/1471-2334-12-14","journal-title":"BMC Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00245.x","article-title":"Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients","volume":"67","author":"Kumar MS","year":"2005","unstructured":"Kumar MS, Sierka DR, Damask AM, et al.. Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients. Kidney Int. 2005, 67:1622-9. 10.1111\/j.1523-1755.2005.00245.x","journal-title":"Kidney Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2021.1915989","article-title":"Pneumocystis jirovecii: a review with a focus on prevention and treatment","volume":"22","author":"Weyant RB","year":"2021","unstructured":"Weyant RB, Kabbani D, Doucette K, Lau C, Cervera C. Pneumocystis jirovecii: a review with a focus on prevention and treatment. Expert Opin Pharmacother. 2021, 22:1579-92. 10.1080\/14656566.2021.1915989","journal-title":"Expert Opin Pharmacother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1086\/515658","article-title":"Risk factors for primary Pneumocystis carinii pneumonia in human immunodeficiency virus-infected adolescents and adults in the United States: reassessment of indications for chemoprophylaxis","volume":"178","author":"Kaplan JE","year":"1998","unstructured":"Kaplan JE, Hanson DL, Navin TR, Jones JL. Risk factors for primary Pneumocystis carinii pneumonia in human immunodeficiency virus-infected adolescents and adults in the United States: reassessment of indications for chemoprophylaxis. J Infect Dis. 1998, 178:1126-32. 10.1086\/515658","journal-title":"J Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199503163321101","article-title":"A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group","volume":"332","author":"Bozzette SA","year":"1995","unstructured":"Bozzette SA, Finkelstein DM, Spector SA, et al.. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med. 1995, 332:693-9. 10.1056\/NEJM199503163321101","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199904293401701","article-title":"Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study","volume":"340","author":"Furrer H","year":"1999","unstructured":"Furrer H, Egger M, Opravil M, et al.. Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study. N Engl J Med. 1999, 340:1301-6. 10.1056\/NEJM199904293401701","journal-title":"N Engl J Med"},{"key":"ref15","unstructured":"Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV. (2023). Accessed. September 6, 2024: https:\/\/clinicalinfo.hiv.gov\/sites\/default\/files\/guidelines\/documents\/adult-adolescent-oi\/guidelines-adult-adolescent...."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/208871-pneumocystis-jirovecii-pneumonia-and-hiv-associated-nephropathy-in-acute-hiv-infection","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T15:22:23Z","timestamp":1726068143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/208871-pneumocystis-jirovecii-pneumonia-and-hiv-associated-nephropathy-in-acute-hiv-infection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.69189","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,11]]}}}